Analysts cut Envision price target: 4 points

Bank of America reduced its price target on Envision healthcare from $72 to $60 earlier this week, according to Dispatch Tribunal.

Advertisement

Here are four key points:

1. The firm has a “buy” rating on Envision shares.

2. On Aug. 24, Jefferies set a $71 price target on Envision shares.

3. Envision shares have a 50-day moving average of $46.95 and 200-day moving average of $54.97.

4. The company’s market cap is $4.88 billion.

More articles on surgery centers:
Hospital surgery center scrutinized for increased case load — board considers CON review
Illinois hospital breaks ground on $95M surgery center — 3 insights
USPI, Montana health system open surgery center; USPI/Tenet adds 3 centers in 8-month period & more: 4 ASC company key notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.